Suchergebnisse - "Fedenko, Alexander"

PubPharm (48)

1

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Wu, Y. | Dziadziuszko, R. | Ahn, J. | +120

2

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4) : an international, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von Kristeleit, R. | Lisyanskaya, A. | Fedenko, A. | +22

CommentIn: Lancet Oncol. 2022 Apr;23(4):440-441. - PMID 35298905

3

Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas : A case report

enthalten in: Frontiers in oncology | 2022

von Kornietskaya, A. | Evdokimova, S. | Kachmazov, A. | +7

4

Remission of a Primary, Recurrent Thoracic Ewing Sarcoma in a 74-year-old woman

enthalten in: Rare tumors | 2022

von Tungate, R. | Lara, K. | Patel, D. | +2

5

Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation : A case report and literature review

enthalten in: Frontiers in oncology | 2022

von Kachmazov, A. | Bolotina, L. | Kornietskaya, A. | +3

6

Systemic therapies in advanced epithelioid haemangioendothelioma : A retrospective international case series from the World Sarcoma Network and a review of literature

enthalten in: Cancer medicine | 2021

von Frezza, A. | Ravi, V. | Lo Vullo, S. | +27

7

Bizarre parosteal osteochondromatous proliferation : Rare case affecting distal ulna and review of literature

enthalten in: Clinical imaging | 2021

von Washington, E. | Menendez, L. | Fedenko, A. | +1

8

Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas : The ANNOUNCE Randomized Clinical Trial

enthalten in: JAMA | 2020

von Tap, W. | Wagner, A. | Schöffski, P. | +19

CommentIn: JAMA. 2020 Apr 7;323(13):1251-1252. - PMID 32259216

9

Systemic treatments in MDM2 positive intimal sarcoma : A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network

enthalten in: Cancer | 2020

von Frezza, A. | Assi, T. | Lo Vullo, S. | +36

10

Systemic treatments in MDM2 positive intimal sarcoma : A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network

enthalten in: Cancer | 2020

von Frezza, A. | Assi, T. | Lo Vullo, S. | +36

1
2
3
4
5
Nächster »
[5]